Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S6 kinase A5 (RPS6KA5, also called MSK1) is a serine/threonine-protein kinase encoded on human chromosome 14 and part of the ribosomal S6 kinase family. It transduces signals from mitogens and cellular stress to a range of transcription factors and histone proteins via phosphorylation. RPS6KA5 modulates gene activation, influences immune and inflammatory responses, and has been implicated in multiple pathways related to cancer biology, neurological processes, and development. Its activities are critical for proper cell signaling, transcriptional regulation, and stress-adaptive gene expression; dysregulation may influence pathologies such as cancer, inflammatory disease, and rare genetic syndromes.
For hypothetical or investigational inhibitors, the mechanism of action could involve competitive inhibition of ATP binding, blockage of kinase activity, suppression of downstream phosphorylation events (e.g., of transcription factors, histones), and attenuation of pro-inflammatory or proliferative signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S6 kinase A5 (RPS6KA5).